To continue using this website, please tell us a
little about yourself:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here

Login

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
 
 
Poll

What are you doing with your equity exposure following 2016’s falls?

I’m upping exposure
I’m keeping it the same
I’m selling down exposure

Vote

 
Search

News & Research

Four early-bird AIM stocks for your 2016 ISA
By Daniel Lanyon | 07:00 | 06-Feb-2016
Graham Spooner, investment research analyst at The Share Centre, reveals the four AIM stocks he tips for investors this ISA season. ...
TopBannerImage
 
Nick Train, Richard Woolnough and mid-caps: Our best stories of the week
By The FE Trustnet team | 16:30 | 05-Feb-2016
In this weekly round-up, the FE Trustnet team highlight its favourite articles of the week including an interview with star manager Nick Train and some detailed analysis of UK mid-cap funds. ...
 
Weekly share-tip roundup: Buy AstraZeneca, sell BP
By Tony Cross | 15:15 | 05-Feb-2016
Questor warned BP’s dividend is not sustainable, while Tempus said investors shouldn’t be put off by the expiring patent on AstraZeneca’s anti-cholesterol drug Crestor. ...
 
More research»

Key indices

chart
Time Span Go
For more indices »
 
 
 
 
Data provided by FE. Care has been taken to ensure that the information is correct, but FE neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.